Cargando…

The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma()

Angiopoietin 2 (Ang2) is a secreted glycoprotein upregulated at sites of angiogenesis and has been implicated in cancer neovascularization. Recent studies have suggested efficacy of combined Ang and vascular endothelial growth factor receptor (VEGFR) inhibition for patients with metastatic renal cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaoen, Bullock, Andrea J., Zhang, Liang, Wei, Lin, Yu, Dongyin, Mahagaokar, Kedar, Alsop, David C., Mier, James W., Atkins, Michael B., Coxon, Angela, Oliner, Jon, Bhatt, Rupal S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101387/ https://www.ncbi.nlm.nih.gov/pubmed/24704536 http://dx.doi.org/10.1016/j.tranon.2014.02.003

Ejemplares similares

High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
por: Wang, Xiaoen, et al.
Publicado: (2011)

Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression
por: Zhang, Liang, et al.
Publicado: (2011)

Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma
por: Wang, Xiaoen, et al.
Publicado: (2016)

Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts
por: Wang, X, et al.
Publicado: (2013)

Combining VEGF receptor inhibitors and angiotensin-(1–7) to target renal cell carcinoma
por: Walther, Thomas, et al.
Publicado: (2021)

Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives
por: Bupathi, Manojkumar, et al.
Publicado: (2014)

Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
por: Kiss, Elina A., et al.
Publicado: (2019)

Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?
por: de Jong, Gerdie M., et al.
Publicado: (2016)

Management of metastatic renal cell carcinoma in patients with poor prognosis
por: Bullock, Andrea, et al.
Publicado: (2010)

Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
por: Ng, Kevin Tak-Pan, et al.
Publicado: (2014)

Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2018)

Tubular Overexpression of Angiopoietin-1 Attenuates Renal Fibrosis
por: Singh, Sudhir, et al.
Publicado: (2016)

Predictive Markers of Efficacy for an Angiopoietin-2 Targeting Therapeutic in Xenograft Models
por: Triana-Baltzer, Gallen, et al.
Publicado: (2013)

Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
por: Whitehead, Michael, et al.
Publicado: (2019)

Association of serum angiopoietin-1, angiopoietin-2 and angiopoietin-2 to angiopoietin-1 ratio with heart failure in patients with acute myocardial infarction
por: CHEN, SHAOMIN, et al.
Publicado: (2013)

The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
por: Vanderborght, Bart, et al.
Publicado: (2020)

Angiopoietin-2: A New Therapeutic Target for Preventing Lung Dysfunction in Sepsis?
Publicado: (2006)

The renal angiopoietin/Tie2 system in lethal human sepsis
por: Aslan, Adnan, et al.
Publicado: (2014)

Association of Angiopoietin-2 with Renal Outcome in Chronic Kidney Disease
por: Tsai, Yi-Chun, et al.
Publicado: (2014)

Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma
por: Choi, Gwang Hyeon, et al.
Publicado: (2021)

Cooperation of Angiopoietin-2 and Angiopoietin-4 in Schlemm's Canal Maintenance
por: Kapiainen, Emmi, et al.
Publicado: (2022)

Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease
por: Chugh, Sumant S., et al.
Publicado: (2014)

Angiopoietin-Like 3: From Discovery to Therapeutic Gene Editing
por: Wang, Xiao, et al.
Publicado: (2019)

Angiopoietins lack of prognostic significance in ductal mammary carcinoma
por: Rmali, Khaled A, et al.
Publicado: (2007)

Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target
por: Melegari, Gabriele, et al.
Publicado: (2022)

Angiopoietin-2 and Angiopoietin-2/Angiopoietin-1 Ratio as Indicators of Potential Severity of Plasmodium vivax Malaria in Patients with Thrombocytopenia
por: Gomes, Luciano Teixeira, et al.
Publicado: (2014)

Prognostic significance of the angiopoietin-2/angiopoietin-1 and angiopoietin-1/Tie-2 ratios for early sepsis in an emergency department
por: Fang, Yingying, et al.
Publicado: (2015)

Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma
por: Rautiola, Juhana, et al.
Publicado: (2016)

Correction: Angiopoietin-2 and Angiopoietin-2/Angiopoietin-1 Ratio as Indicators of Potential Severity of Plasmodium vivax Malaria in Patients with Thrombocytopenia
Publicado: (2015)

Correlation between plasma angiopoietin-1, angiopoietin-2 and matrix metalloproteinase-2 in coronary heart disease
por: Wu, Haoyu, et al.
Publicado: (2016)

Angiopoietins and diabetic nephropathy
por: Gnudi, Luigi
Publicado: (2016)

Angiopoietin-1, Angiopoietin-2 and Bicarbonate as Diagnostic Biomarkers in Children with Severe Sepsis
por: Wang, Kun, et al.
Publicado: (2014)

Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic Kidney Disease
por: Tsai, Yi-Chun, et al.
Publicado: (2016)

Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
por: Sylvers-Davie, Kelli L., et al.
Publicado: (2021)

Role of Angiopoietin/Tie2 in Critical Illness: Promising Biomarker, Disease Mediator, and Therapeutic Target?
por: Lukasz, Alexander, et al.
Publicado: (2012)

Angiopoietin-1 deficiency increases renal capillary rarefaction and tubulointerstitial fibrosis in mice
por: Loganathan, Krishnapriya, et al.
Publicado: (2018)

Angiopoietins as Potential Targets in Management of Retinal Disease
por: Khanani, Arshad M, et al.
Publicado: (2021)

Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2
por: Nguyen, Vicky PKH, et al.
Publicado: (2007)

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
por: Hernández-Bartolomé, Ángel, et al.
Publicado: (2016)

In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target
por: ten Voorde, Anna M.W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t7gbdr3scoiuf639p4b59r5ktj